Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 19.91 CNY -0.8% Market Closed
Market Cap: 56.7B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note
Shanghai Pharmaceuticals Holding Co Ltd
/
Income Statement
/
Cost of Revenue

Shanghai Pharmaceuticals Holding Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cost of Revenue
-¥242.7B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-12%
Sinopharm Group Co Ltd
HKEX:1099
Cost of Revenue
-¥543.2B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cost of Revenue
-¥137.8B
CAGR 3-Years
-7%
CAGR 5-Years
-9%
CAGR 10-Years
-14%
C
China National Medicines Corp Ltd
SSE:600511
Cost of Revenue
-¥47.5B
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-16%
Huadong Medicine Co Ltd
SZSE:000963
Cost of Revenue
-¥28.2B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Cost of Revenue
-¥66.9B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-12%
No Stocks Found

Shanghai Pharmaceuticals Holding Co Ltd
Glance View

Market Cap
56.7B CNY
Industry
Health Care

Shanghai Pharmaceuticals Holding Co Ltd, a giant in China's pharmaceutical industry, operates with a dual-engine strategy that seamlessly combines manufacturing and distribution. Established in the bustling metropolis of Shanghai, the company has swiftly become a cornerstone of China's healthcare landscape. Its manufacturing arm is a powerhouse of innovation and production, turning out a vast array of pharmaceutical products that encompass both traditional Chinese medicine and modern pharmaceuticals. These products range from patented medicines to essential generics, entering hospitals, clinics, and retail pharmacies nationwide, all the while feeding a robust supply chain that caters to the country's vast and diverse market needs. On the flip side, Shanghai Pharmaceuticals' extensive distribution network is the lifeline that ensures these vital medicines reach their destinations safely and efficiently. In an era where logistics and supply chain management are pivotal, the company excels through an advanced distribution system that connects manufacturers with end-users across China. This network is bolstered by strategic partnerships and a commitment to technological advancement, allowing the company to maintain agility and reliability in an ever-evolving market. Revenue streams flow not just from product sales but are heavily supplemented through strategic partnerships and services that enhance accessibility and affordability for healthcare providers and patients alike. As one of the top pharmaceutical firms in China, Shanghai Pharmaceuticals is adept at maneuvering the intricacies of healthcare demands, regulatory landscapes, and competitive dynamics, carving its niche as a leader in both innovation and distribution efficiency.

Intrinsic Value
45.73 CNY
Undervaluation 56%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Cost of Revenue?
Cost of Revenue
-242.7B CNY

Based on the financial report for Sep 30, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Cost of Revenue amounts to -242.7B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-12%

Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been -10% over the past three years , -9% over the past five years , and -12% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 216,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.